BELVIQ XR
- Product NDC
- 62856-535
- 11-digit product format
- 628560535
- Labeler code
- 62856
- Product ID
- 62856-535_56a5ecbb-948c-4dda-b6ce-6b0086f2e293
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lorcaserin hydrochloride hemihydrate
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Eisai Inc.
- Application
- NDA208524
- Marketing category
- NDA
- Marketing start
- 2016-07-15
- Marketing end
- 2022-05-31
- Substance
- LORCASERIN HYDROCHLORIDE HEMIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62856-535-30 | 62856053530 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62856-535-30) | 2016-07-15 | 2022-05-31 | No | No | Current |